In our work, sCAR-PPAb enhanced phagocytosis of K562/ADR cells by macrophages through binding with SLMAP on K562/ADR, indicating an interaction between drug resistant cancer cells and macrophages, as well as a role of SLMAP in mediating the interaction. Here, SLMAP is linked to cancer.